Page last updated: 2024-09-03

mozavaptan and Cyst

mozavaptan has been researched along with Cyst in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baeßler, B; Benzing, T; Borgal, L; Dafinger, C; Franke, M; Göbel, H; Höhne, M; Koerber, F; Maintz, D; Persigehl, T; Schermer, B; Vechtel, J1
de Heer, E; Gansevoort, RT; Meijer, E; Peters, DJ; van Goor, H; Veraar, KA; Versteeg, IB; Zittema, D1

Other Studies

2 other study(ies) available for mozavaptan and Cyst

ArticleYear
Magnetic resonance T2 mapping and diffusion-weighted imaging for early detection of cystogenesis and response to therapy in a mouse model of polycystic kidney disease.
    Kidney international, 2017, Volume: 92, Issue:6

    Topics: Adult; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cysts; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Early Diagnosis; Female; Humans; Image Processing, Computer-Assisted; Kidney; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Targeted Therapy; Mutation; NIMA-Related Kinases; Polycystic Kidney Diseases; Proof of Concept Study; Time Factors; Treatment Outcome; Young Adult

2017
Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease.
    American journal of nephrology, 2016, Volume: 44, Issue:3

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cysts; Disease Models, Animal; Drinking; Female; Kidney; Male; Mice, Knockout; Organ Size; Polycystic Kidney, Autosomal Dominant; Protein Kinase C; Time Factors; Water

2016
chemdatabank.com